Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594 | Zendy

Maria G. RamosZavala | Zendy; Manuel González-Ortı́z | Zendy; Esperanza MartínezAbundis | Zendy; José Antonio Robles-Cervantes | Zendy; Roberto González-López | Zendy; Nestor J. Santiago-Hernández | Zendy

Open Access

Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594

Author(s) -

Maria G. RamosZavala,

Manuel González-Ortı́z,

Esperanza MartínezAbundis,

José Antonio Robles-Cervantes,

Roberto González-López,

Nestor J. Santiago-Hernández

Publication year - 2012

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc11-2035

Subject(s) - medicine , type 2 diabetes , diabetes mellitus , randomized controlled trial , drug , obesity , insulin , metabolic control analysis , endocrinology , pharmacology

We thank Tobar et al. (1) for sharing the brief results and conclusions of an elegant study in an animal model of obesity and type 2 diabetes that allowed confirmation of the antihyperglycemic effect of diacerein, a medication frequently used in the treatment of rheumatic diseases, and the responsible mechanisms by which …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research